Limbic encephalitis
Autoimmune brain inflammation with memory loss and psychiatric symptoms.
Limbic encephalitis is a form of encephalitis characterized by inflammation of the brain, caused by autoimmunity where the body produces antibodies against itself. First described by Brierley and others in 1960 as a series of three cases, the disease is associated with cancer in some cases and not in others, and its link to cancer was first noted in 1968.
- First described
- 1960
- Cancer link noted
- 1968
- Field
- Neurology, Immunology
- Classification
- Paraneoplastic and non-paraneoplastic
- Common antibodies
- Anti-Hu, Anti-Ma2, Anti-NMDAR, Anti-VGKC-complex
- Hallmark symptom
- Subacute short-term memory deficits
Lore & Background
Limbic encephalitis is broadly grouped into paraneoplastic limbic encephalitis (PNLE), caused by cancer or tumor, and non-paraneoplastic limbic encephalitis (NPLE), not associated with cancer. NPLE is more common and is an autoimmune disorder, not caused by direct infection like herpes simplex virus. The disease is seldom limited to the limbic system, with post-mortem studies showing involvement of other brain parts. Symptoms develop over days or weeks, with short-term memory deficits as the hallmark, often overshadowed by headache, irritability, sleep disturbance, delusions, hallucinations, agitation, seizures, or psychosis.
Reader's Guide
Limbic encephalitis is significant as a rare but important cause of rapidly progressive cognitive decline and psychiatric symptoms, often misdiagnosed as herpes simplex encephalitis or primary psychiatric disorders. Its classification by auto-antibody type guides treatment and prognosis: anti-Hu associated with small-cell lung carcinoma, anti-Ma2 with testicular germ-cell tumors, anti-NMDAR with ovarian teratomata, and anti-VGKC-complex often non-paraneoplastic. Diagnosis is extremely difficult, delayed by weeks, as key antibody tests are not routinely offered and some have no commercial assay. Treatment lacks randomized trials; options include intravenous immunoglobulin, plasmapheresis, corticosteroids, cyclophosphamide, and rituximab. Recovery in paraneoplastic cases requires complete tumor removal, which is not always possible. The disease highlights the intersection of neurology, oncology, and immunology, and its recognition has expanded since 1999 with reports of non-paraneoplastic cases responding to immunosuppression.
Did You Know?
- Non-paraneoplastic limbic encephalitis is more common than the paraneoplastic form.
- Anti-NMDAR encephalitis is strongly associated with benign tumours of the ovary, usually teratomata or dermoid cysts.
- Patients with anti-VGKC-complex encephalitis may have a completely normal cerebrospinal fluid examination.
More in Steroid-responsive inflammatory conditions 1-24
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced